309 related articles for article (PubMed ID: 29030392)
1. Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection.
Bibli SI; Szabo C; Chatzianastasiou A; Luck B; Zukunft S; Fleming I; Papapetropoulos A
Mol Pharmacol; 2017 Dec; 92(6):718-730. PubMed ID: 29030392
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2.
Bibli SI; Zhou Z; Zukunft S; Fisslthaler B; Andreadou I; Szabo C; Brouckaert P; Fleming I; Papapetropoulos A
Cardiovasc Res; 2017 Jul; 113(8):926-937. PubMed ID: 28444132
[TBL] [Abstract][Full Text] [Related]
3. The cystathionine γ-lyase/hydrogen sulfide pathway mediates the trimetazidine-induced protection of H9c2 cells against hypoxia/reoxygenation-induced apoptosis and oxidative stress.
Zheng W; Liu C
Anatol J Cardiol; 2019 Sep; 22(3):102-111. PubMed ID: 31475956
[TBL] [Abstract][Full Text] [Related]
4. Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide.
Tsai CY; Wen SY; Shibu MA; Yang YC; Peng H; Wang B; Wei YM; Chang HY; Lee CY; Huang CY; Kuo WW
Int J Cardiol; 2015 Sep; 195():300-10. PubMed ID: 26056963
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
6. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
[TBL] [Abstract][Full Text] [Related]
9. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes.
Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B
Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
Xiao L; Dong JH; Teng X; Jin S; Xue HM; Liu SY; Guo Q; Shen W; Ni XC; Wu YM
J Hypertens; 2018 Mar; 36(3):651-665. PubMed ID: 29084084
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin.
Fisslthaler B; Loot AE; Mohamed A; Busse R; Fleming I
Circ Res; 2008 Jun; 102(12):1520-8. PubMed ID: 18483407
[TBL] [Abstract][Full Text] [Related]
14. H
Nandi SS; Mishra PK
Sci Rep; 2017 Jun; 7(1):3639. PubMed ID: 28623294
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent.
King AL; Polhemus DJ; Bhushan S; Otsuka H; Kondo K; Nicholson CK; Bradley JM; Islam KN; Calvert JW; Tao YX; Dugas TR; Kelley EE; Elrod JW; Huang PL; Wang R; Lefer DJ
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3182-7. PubMed ID: 24516168
[TBL] [Abstract][Full Text] [Related]
16. H
Hazzaa SM; Elsayed Arafat ESE; Abdo Ismail AE; Eltorgoman AEA; Abdelaziz SA; Kombr YFA; Zidan RA; Assar MF
Tissue Cell; 2021 Oct; 72():101550. PubMed ID: 33915356
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide facilities production of nitric oxide via the Akt/endothelial nitric oxide synthases signaling pathway to protect human umbilical vein endothelial cells from injury by angiotensin II.
Cui J; Zhuang S; Qi S; Li L; Zhou J; Zhang W; Zhao Y; Qi N; Yin Y; Huang L
Mol Med Rep; 2017 Nov; 16(5):6255-6261. PubMed ID: 28849094
[TBL] [Abstract][Full Text] [Related]
18. Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway.
Gong H; Chen Z; Zhang X; Li Y; Zhang J; Chen Y; Ding Y; Zhang G; Yang C; Zhu Y; Zou Y
Int J Mol Sci; 2015 Jun; 16(6):12482-98. PubMed ID: 26047336
[TBL] [Abstract][Full Text] [Related]
19. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
[TBL] [Abstract][Full Text] [Related]
20. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
